Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evoked potentials for evaluation of multiple sclerosis.

P Fuhr1, L Kappos

  • 1Department of Neurology, University of Basel, Basel, Switzerland. peter.fuhr@unibas.ch

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|December 12, 2001
PubMed
Summary

Evoked potentials (EP) are valuable for assessing multiple sclerosis (MS), aiding in disease monitoring and prediction, especially when compared to MRI. Future advancements may enable personalized MS subtype differentiation and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

Journal of neurology·2023
Same author

Fully Automatic Method for Reliable Spinal Cord Compartment Segmentation in Multiple Sclerosis.

AJNR. American journal of neuroradiology·2023
Same author

Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentials.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2022
Same author

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2020
Same author

Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.

European journal of neurology·2020
Same author

Facing privacy in neuroimaging: removing facial features degrades performance of image analysis methods.

European radiology·2019

Area of Science:

  • Neuroscience
  • Clinical Neurology

Background:

  • The role of evoked potentials (EP) in multiple sclerosis (MS) assessment has evolved due to advancements in imaging technologies.
  • Magnetic Resonance Imaging (MRI) offers higher diagnostic sensitivity for MS.
  • Despite MRI's sensitivity, EP remain clinically relevant in various situations.

Purpose of the Study:

  • To evaluate the current utility of evoked potentials (EP) in the assessment and monitoring of multiple sclerosis (MS).
  • To compare the efficacy of EP with conventional MRI in disease monitoring and prediction.
  • To explore the future potential of EP in differentiating MS subtypes and personalizing treatment.

Main Methods:

  • Review of recent studies on the application of evoked potentials (EP) in multiple sclerosis (MS).

Related Experiment Videos

  • Comparative analysis of EP and conventional MRI in disease assessment and prediction.
  • Exploration of emerging electrophysiological, immunological, and imaging techniques.

    • Main Results:

    • Evoked potentials (EP) are useful for monitoring and predicting the course of multiple sclerosis (MS) in patient groups.
    • EP demonstrate superior performance over conventional MRI for disease monitoring and prediction purposes.
    • Current imaging techniques like MRI have greater diagnostic sensitivity for MS detection.

    Conclusions:

    • Evoked potentials (EP) continue to be a valuable tool in multiple sclerosis (MS) assessment, particularly for monitoring and prediction.
    • Future developments in electrophysiology, immunology, and imaging may facilitate early differentiation of MS subtypes.
    • Personalized therapeutic strategies for MS patients could be developed based on early subtype identification.